Scotland · NHS Scotland MSAN
Methylphenidate prolonged-release tablets
MSAN(2024)48 · Level 3 · issued 23 Aug 2024
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| 1. Methylphenidate prolonged-release tablet brands are in limited supply and intermittent regional | Limited supply | — |
| 2. Lisdexamfetamine (Elvanse®, Elvanse Adult®) capsules remain available and can support | Available | — |
| 4. Methylphenidate (Equasym® XL) modified-release capsules remain available but cannot | Available | — |
| as lisdexamfetamine capsules remain available, consider appropriateness of prescribing as | Available | — |
| Registration for access to the website is available to UK healthcare professionals and | Available | — |
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.